Patent · US Active

Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)

US7691905B2 · kind B2 · utility

3Cited by
8References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2003
Grant dateApr 6, 2010
Priority date
Expiry dateDec 20, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.